tm logo
REJUVENRX
ADVERTISED

on 23 Oct 2024

Last Applicant/ Owned by

REJUVENRX INC.

2950 chemin PolytechniqueMontréal

QUEBEC

CA

H3T1J4

Serial Number

2073225 filed on 23rd Dec 2020

Correspondent Address

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

REJUVENRX

Trademark usage description

pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system d Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, inflammatory muscle diseases and disorders, and central nervous system diseases and disorders, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease.


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines.


Classification kind code

11

Mark Details


Serial Number

2073225

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 23rd Oct 2024
Advertised
Submitted for opposition 27
on 26th Sep 2024
Approval Notice Sent
Submitted for opposition 26
on 26th Sep 2024
Approved
Submitted for opposition 22
on 18th Sep 2024
Search Recorded
Submitted for opposition 67
on 15th Dec 2023
Agent Name Changed
Submitted for opposition 287
on 27th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 23rd Dec 2020
Filed
Submitted for opposition 1
on 23rd Dec 2020
Created
Submitted for opposition 31
on 23rd Dec 2020
Formalized